About CoapTech
CoapTech is a company based in Baltimore (United States) founded in 2016. CoapTech has raised $16.52 million across 11 funding rounds from investors including NIH, HHS and TEDCO. CoapTech offers products and services including PUMA-G System and PUG Procedure. CoapTech operates in a competitive market with competitors including EndoGastric Solutions, EndoChoice, Rockfield, Reliefband and Endo Tools Therapeutics, among others.
- Headquarter Baltimore, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.52 M (USD)
in 11 rounds
-
Latest Funding Round
$7.07 M (USD), Series B
Aug 27, 2024
-
Investors
NIH
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CoapTech
CoapTech offers a comprehensive portfolio of products and services, including PUMA-G System and PUG Procedure.
Ultrasound-based solution for bedside feeding tube placement to enhance safety.
Method for percutaneous ultrasound gastrostomy to reduce hospital stay lengths.
People of CoapTech
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of CoapTech
CoapTech has successfully raised a total of $16.52M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $7.07 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CoapTech
CoapTech has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for CoapTech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CoapTech
Investment portfolio details for CoapTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CoapTech
Detailed financials for CoapTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Coaptech Comparisons
Peer comparison for CoapTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CoapTech
CoapTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EndoGastric Solutions, EndoChoice, Rockfield, Reliefband and Endo Tools Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Incisionless transoral procedures for upper GI diseases are developed.
|
|
| Locked | Locked | Locked |
Devices, systems, and services are provided for GI specialists.
|
|
| Locked | Locked | Locked |
Developer of a medical device for the feeding sector
|
|
| Locked | Locked | Locked |
Wearable device is developed for nausea and vomiting relief.
|
|
| Locked | Locked | Locked |
Endoscopic catheters for precision in gastroenterology are developed.
|
Detailed competitors of CoapTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Coaptech
Complete news archive for CoapTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoapTech
CoapTech was founded in 2016 and raised its 1st funding round 1 year after it was founded.
CoapTech is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
CoapTech is a funded company, having raised a total of $16.52M across 11 funding rounds to date.
CoapTech was founded in 2016 in Baltimore, United States, within the medical device sector. A minimally invasive approach for gastrostomy feeding tube placement is provided through the PUMA-G system and the percutaneous ultrasound gastrostomy (PUG) procedure. Magnetic components are employed, including one affixed to an inserted catheter and another for external guidance and control. Operations focus on enhancing patient outcomes in gastrointestinal interventions.
CoapTech's top competitors include Endo Tools Therapeutics, EndoChoice and Rockfield.
CoapTech offers PUMA-G System and PUG Procedure.
CoapTech has 7 investors. Key investors include NIH, HHS, TEDCO, Hunniwell Lake Ventures, and National Institute of Diabetes and Digestive and Kidney Diseases.